MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling

Androgen deprivation therapy (ADT) is the main therapeutic option for advanced prostate cancer (PCa). After initial regression, most tumors develop into castration-resistant PCa (CRPC). Previously, we found the Mediator complex subunit MED15 to be overexpressed in CRPC and to correlate with clinical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Offermann, Anne, Vlasic, Ignacija, Syring, Isabella, Vogel, Wenzel, Ruiz, Christian, Zellweger, Tobias, Rentsch, Cyrill A, Hagedorn, Susanne, Behrends, Jochen, Nowak, Michael, Merseburger, Axel, Bubendorf, Lukas, Kirfel, Jutta, Duensing, Stefan, Adler, David, Perner, Sven
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352374/
https://ncbi.nlm.nih.gov/pubmed/27974704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13860
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars